台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    98.0
  • 漲跌
    ▲0.2
  • 漲幅
    +0.20%
  • 成交量
    411
  • 產業
    上市 生技醫療類股
  • 354人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
旭富 (4119)籌碼相關-富邦-頭份 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-頭份 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/2100.00197.6098.00-1178-0.57%
2024/11/1900.00196.1096.10-1155-0.64%
2024/11/1500.000.595.1095.50-0.5147-0.31%
2024/11/14194.0000.0094.9011420.70%
2024/11/1100.000.193.5093.30-0.1112-0.05%
2024/11/010.190.0000.0090.000.11140.05%
2024/10/1700.000.290.0090.20-0.2128-0.16%
2024/08/22188.9000.0089.0011770.56%
2024/08/13489.95389.9089.5011980.50%
2024/06/2000.001090.3390.20-10206-4.85%
2024/06/1800.00390.3090.40-3206-1.46%
2024/06/1200.00290.3590.40-2211-0.95%
2024/06/061392.8800.0092.40132185.94%
2024/06/0400.00192.8092.50-1228-0.44%
2024/05/28192.6000.0092.5012350.42%
2024/05/2300.00191.4091.30-1235-0.42%
2024/05/1500.000.191.4091.50-0.1222-0.02%
2024/05/100.191.0600.0090.900.12400.02%
2024/05/0800.001.587.9388.80-1.5242-0.61%
2024/04/2400.000.288.0087.80-0.2245-0.09%
2024/04/1000.000.189.5089.50-0.1261-0.04%
2024/03/28188.4000.0088.3012580.39%
2024/03/2600.00187.2087.20-1260-0.38%
2024/03/1200.0014.189.0789.00-14.1278-5.06%
2024/03/080.190.9000.0090.400.12730.02%
2024/01/0900.00197.6097.30-1317-0.32%
2024/01/051100.0000.00100.0013170.32%
2023/12/2700.00097.3097.1003140.00%
2023/12/2500.00196.2096.30-1311-0.32%
2023/12/2100.000.197.9097.80-0.1308-0.02%
2023/12/180.197.5000.0097.500.13020.02%
2023/12/12193.2000.0093.3012790.36%
2023/12/0800.00091.7092.000279-0.01%
2023/11/270.192.0000.0090.800.12610.04%
2023/11/21189.3000.0089.3012510.40%
2023/11/0900.006.588.8489.00-6.5223-2.89%
2023/10/03097.3000.0096.9002590.01%
2023/09/1900.000.896.5096.00-0.8283-0.26%
2023/09/1300.00297.5096.60-2293-0.68%
2023/09/1200.00298.5098.00-2295-0.68%
2023/09/0400.00199.6099.60-1298-0.33%
2023/08/2500.00199.60101.50-1304-0.33%
2023/08/171101.0000.00101.5013220.31%
2023/08/1600.002101.00101.00-2324-0.62%
2023/08/1500.001101.50102.00-1329-0.30%
2023/08/143100.60299.90100.0013340.30%
2023/08/104104.7500.00104.5043431.16%
2023/08/084103.5000.00103.0043731.07%
2023/08/078104.0600.00104.0083792.11%
2023/08/042104.0000.00105.0023840.52%
2023/08/012103.5000.00103.0023930.51%
2023/07/1200.003104.33104.00-3464-0.65%
2023/07/101110.5000.00108.5014700.21%
2023/07/041117.5000.00117.5014690.21%
2023/06/2100.000116.50116.5005340.00%
2023/06/201118.0000.00117.0015370.19%
2023/06/1500.002117.00117.00-2543-0.37%
2023/06/092117.5000.00117.0026950.29%
2023/05/310118.0000.00118.0007820.00%
2023/05/2600.001113.50113.00-1801-0.12%
2023/05/193116.5000.00115.5038960.33%
2023/05/181119.0000.00118.0018920.11%
2023/05/151115.0000.00116.5018750.11%
2023/05/101126.0000.00128.0018670.12%
2023/05/021125.501126.50125.5008540.00%
2023/04/251127.001126.50127.0008440.00%
2023/04/1300.001125.00125.50-1759-0.13%
2023/04/1200.001125.00124.50-1750-0.13%
2023/04/1100.001123.50124.00-1749-0.13%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章